|
Q4 FY2025
As of Apr 30, 2026
|
Q3 FY2025
As of Jan 31, 2026
|
Q2 FY2025
As of Oct 31, 2025
|
Q1 FY2025
As of Jul 31, 2025
|
Q4 FY2024
As of Apr 30, 2025
|
Q3 FY2024
As of Jan 31, 2025
|
Q2 FY2024
As of Oct 31, 2024
|
Q1 FY2024
As of Jul 31, 2024
|
Q4 FY2023
As of Apr 30, 2024
|
Q3 FY2023
As of Jan 31, 2024
|
Q2 FY2023
As of Oct 31, 2023
|
Q1 FY2023
As of Jul 31, 2023
|
Q4 FY2022
As of Apr 30, 2023
|
Q3 FY2022
As of Jan 31, 2023
|
Q2 FY2022
As of Oct 31, 2022
|
Q1 FY2022
As of Jul 31, 2022
|
Q3 FY2021
As of Jan 31, 2022
|
Q2 FY2021
As of Oct 31, 2021
|
Q1 FY2021
As of Jul 31, 2021
|
Q4 FY2020
As of Apr 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Finance lease right-of-use assets, net | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Accrued liabilities - related parties | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Convertible Note Payable | ||||||||||||||||||||
| Convertible note payable, net of debt discount of $0 | ||||||||||||||||||||
| Promissory note payable, net of debt discount of $50,279 and $104,248, respectively | ||||||||||||||||||||
| Finance lease liabilities | ||||||||||||||||||||
| Stock payable - related parties | ||||||||||||||||||||
| Stock payable | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Total stock payable | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Finance lease liabilities - non-current | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Commitments and Contingencies (Note 11) | ||||||||||||||||||||
| Founders Series A Non-Voting Redeemable Preferred Stock, $0.0001 par value, $15 stated value; 500,000 shares authorized; 21,250 and 28,750 shares issued and outstanding at January 31, 2024, and April 30, 2023 respectively | ||||||||||||||||||||
| Series A Non-Voting Redeemable Preferred Stock, $0.0001 par value, $10 stated value; 175,000 designated; 175,000 shares issued and outstanding | ||||||||||||||||||||
| Redeemable preferred stock, value | ||||||||||||||||||||
| Series A Non - Voting Redeemable Preferred Stock | ||||||||||||||||||||
| Founders Series A Non-Voting Redeemable Preferrd stock | ||||||||||||||||||||
| Series A Non-Voting Redeemable Preferred stock | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Founders Class A Common Stock | ||||||||||||||||||||
| Series A Preferred Shares | ||||||||||||||||||||
| Series A Non-Voting Redeemable Preferrd stock | ||||||||||||||||||||
| Founders Series A Non-Voting Redeemable Preferrd stock | ||||||||||||||||||||
| Series A Non-Voting Redeemable Preferred stock | ||||||||||||||||||||
| Founders Series A Non-Voting Redeemable Preferred Stock, $0.0001 par value, $15 stated value; 500,000 shares authorized; 21,250 and 28,750 shares issued and outstanding at October 31, 2023 and April 30, 2023, respectively | ||||||||||||||||||||
| Series C Preferred Shares, $0.0001 par value, 175 shares designated; 17.5 shares and 0 shares issued and outstanding at October 31, 2023 and April 30, 2023, respectively | ||||||||||||||||||||
| Founders Class A Common stock, $0.0001 par value, 10,000,000 shares authorized; 115,000 shares issued and outstanding | ||||||||||||||||||||
| Common stock, $0.0001 par value, 250,000,000 shares authorized; 91,190,126 shares and 76,657,368 shares issued and outstanding issued and outstanding, respectively | ||||||||||||||||||||
| Founders Class A Common Stock | ||||||||||||||||||||
| Total common stock, $0.0001 par value, 250,000,000 shares authorized; 91,190,126 shares and 76,657,368 shares issued and outstanding issued and outstanding, respectively | ||||||||||||||||||||
| Subscription receivable | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Stockholders' Deficit | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
| Redeemable preferred stock, value | ||||||||||||||||||||
| Series A Non - Voting Redeemable Preferred Stock | ||||||||||||||||||||
| Founder Series A Non Voting Redeemable Preferred Stock | ||||||||||||||||||||
| Founders Series A Non-Voting Redeemable Preferrd stock | ||||||||||||||||||||
| Series A Non-Voting Redeemable Preferred stock | ||||||||||||||||||||
Loading...
